These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9513613)

  • 1. Estrogen therapy in postmenopausal osteoporosis. What we know and what we don't.
    Roux C
    Rev Rhum Engl Ed; 1997 Jun; 64(6):402-9. PubMed ID: 9513613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postmenopausal osteoporosis from the viewpoint of the gynecologist].
    Dören M; Schneider HP
    Z Gesamte Inn Med; 1992 Dec; 47(12):568-72. PubMed ID: 1285464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens in prevention and treatment of osteoporosis.
    Lindsay R
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1806-10. PubMed ID: 2532784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of osteoporosis by the gynecologist].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.
    Palacios S
    Climacteric; 2002 Jun; 5 Suppl 2():32-9. PubMed ID: 12482109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous estrogen in prevention of early postmenopausal bone loss in Chinese women.
    Sun A; Lin S; Yu W; Qin M; Chen F; Zhang Y; Wei Y; de Lignieres B
    Chin Med J (Engl); 2002 Dec; 115(12):1790-5. PubMed ID: 12622925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis.
    Menon KV; Angulo P; Boe GM; Lindor KD
    Am J Gastroenterol; 2003 Apr; 98(4):889-92. PubMed ID: 12738473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route.
    Delmas PD; Marianowski L; Perez Ade C; Ribot C; Pornel B; Palacios S; Lopes P;
    Maturitas; 2004 Jun; 48(2):85-96. PubMed ID: 15172082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy].
    Liu JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):240-3. PubMed ID: 12905731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and treatment of postmenopausal women at risk for the development of osteoporosis.
    Dören M; Schneider HP
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):431-3. PubMed ID: 1490769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Recent evidence of estrogen therapy for osteoporosis].
    Higuchi T; Mizunuma H
    Clin Calcium; 2008 Aug; 18(8):1141-6. PubMed ID: 18677052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy.
    Richman S; Edusa V; Fadiel A; Naftolin F
    Menopause; 2006; 13(1):148-55. PubMed ID: 16607111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.
    Schaefers M; Muysers C; Alexandersen P; Christiansen C
    Menopause; 2009; 16(3):559-65. PubMed ID: 19423999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ossein-hydroxyapatite compounds for preventing postmenopausal bone loss. Coadjuvant use with hormone replacement therapy.
    Castelo-Branco C; Martínez de Osaba MJ; Pons F; Casals E; Sanjuán A; Vicente JJ; Vanrell JA
    J Reprod Med; 1999 Mar; 44(3):241-6. PubMed ID: 10202741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.